Insights
Search Results
Client Highlights
12.15.25
Wilson Sonsini Advises Quantum Computing on $110 Million Acquisition of Luminar Semiconductor
On December 15, 2025, Quantum Computing (QCi), an innovative, quantum optics and integrated photonics technology company, announced that it has signed an agreement to acquire Luminar Semiconductor (LSI), a wholly owned subsidiary of Luminar Technologies, in an all-cash transaction valued at $110 million, subject to customary adjustments. Wilson Sonsini Goodrich & Rosati is advising QCi on the transaction
Client Highlights
12.08.25
Wilson Sonsini Advises Foresight Diagnostics on Acquisition by Natera
On December 5, 2025, Natera, Inc., a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular residual disease (MRD) detection, announced that Natera has completed its acquisition of Foresight in an all-stock transaction consisting of a $275 million upfront payment with an additional $175 million in earnouts tied to the achievement of revenue- and reimbursement-based milestones. Wilson Sonsini Goodrich & Rosati advised Foresight on the transaction.
The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
Client Highlights
11.04.25
Firm Advises Automation Anywhere on Acquisition of Aisera
On November 4, 2025, Automation Anywhere, the leading provider of Agentic Process Automation (APA) and agentic solutions, announced it has acquired Aisera, the leading provider of agentic solutions for autonomous IT. The acquisition expands Automation Anywhere’s deep AI portfolio and expertise in automating mission-critical enterprise processes with Aisera’s industry-leading self-service agents for IT Service Management (ITSM), HR, and Customer Service—creating the industry’s most comprehensive agentic automation portfolios to deliver autonomous operations across departments and improve employee and customer experience. Wilson Sonsini Goodrich & Rosati advised Automation Anywhere on the transaction.
Client Highlights
8.28.25
Wilson Sonsini Advises Uniphore on Orby AI and Autonom8 Transactions
On August 28, 2025, Uniphore, the Business AI company, announced that it has acquired Orby AI, Inc. and intends to acquire Autonom8, Inc., two AI-native companies that will enhance the capabilities of Uniphore’s Business AI Cloud. Both teams bring top AI research and engineering talent from DeepMind and Google, adding unmatched expertise and proven innovation to push the boundaries of Business AI. Wilson Sonsini Goodrich & Rosati advised Uniphore on both transactions.
Client Highlights
1.13.25
Wilson Sonsini Advises Bolt Medical on Merger with Boston Scientific
On January 8, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease, for up to $900 million. Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction.
Client Highlights
1.03.24
Wilson Sonsini Advises ImmunityBio on $320 Million Investment
On January 2, 2024, ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity investment in the company by Oberland Capital, with $210 million of gross proceeds received at closing on December 29, 2023. The additional capital provides significant financial resources for ImmunityBio to accelerate its commercialization efforts in anticipation of a potential regulatory approval, as well as to expand its pipeline within the broader urological cancer space. The proceeds will also be used to fund ongoing business operations and clinical trials expanding N-803 (Anktiva®) indications into multiple solid tumors. Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction.
Client Highlights
5.19.23
Firm Advises GTreasury, a Mainsail Portfolio Company, on Hg Investment
On May 18, 2023, software company GTreasury announced a majority investment from Hg, an investor in global software and services companies. Mainsail Partners, a Wilson Sonsini client and the current majority owner, and members of the GTreasury management team will remain as investors in the business. Wilson Sonsini Goodrich & Rosati advised GTreasury on the transaction.
Client Highlights
5.06.22
Wilson Sonsini Advises Raxium on Acquisition by Google
On May 4, 2022, Google announced it acquired Raxium, an innovator in single panel MicroLED display technologies. Terms of the deal were not disclosed. Wilson Sonsini Goodrich & Rosati represented Raxium in the transaction.
Client Highlights
3.28.22
Wilson Sonsini Represents Poly in $3.3 Billion Acquisition by HP Inc.
On March 28, 2022, HP Inc. announced a definitive agreement to acquire Poly, a leading global provider of workplace collaboration solutions, in an all-cash transaction for $40 per share, implying a total enterprise value of $3.3 billion, inclusive of Poly’s net debt. Wilson Sonsini Goodrich & Rosati is representing Poly in the transaction.
The acquisition accelerates HP’s strategy to create a more growth-oriented portfolio, further strengthens its industry opportunity in hybrid work solutions, and positions the company for long-term, sustainable growth and value creation. Poly will help drive the growth and scale of HP’s peripherals and workforce solutions businesses. Poly’s devices, software, and services, combined with HP’s strengths across compute, device management, and security, create a robust portfolio of hybrid meeting solutions. Poly is a leader in video conferencing solutions, cameras, headsets, voice, and software. Together, HP and Poly will deliver a complete ecosystem of devices, software, and digital services to create premium employee experiences, improve workforce productivity, and provide enterprise customers with better visibility, insights, security, and manageability across their hybrid IT environments.
The acquisition accelerates HP’s strategy to create a more growth-oriented portfolio, further strengthens its industry opportunity in hybrid work solutions, and positions the company for long-term, sustainable growth and value creation. Poly will help drive the growth and scale of HP’s peripherals and workforce solutions businesses. Poly’s devices, software, and services, combined with HP’s strengths across compute, device management, and security, create a robust portfolio of hybrid meeting solutions. Poly is a leader in video conferencing solutions, cameras, headsets, voice, and software. Together, HP and Poly will deliver a complete ecosystem of devices, software, and digital services to create premium employee experiences, improve workforce productivity, and provide enterprise customers with better visibility, insights, security, and manageability across their hybrid IT environments.
Client Highlights
2.03.22
Wilson Sonsini Repesents Revival in Distalmotion’s $90 Million Series E
On January 26, 2022, Distalmotion announced the closing of a $90 million Series E financing (structured as a secured convertible loan) to support the global commercialization of its surgical robot Dexter. Revival Healthcare Capital (Revival) led the round with participation from 415 CAPITAL (415), as well as existing investors.
Client Highlights
1.19.21
Wilson Sonsini Advises Lumentum on $5.7 Billion Acquisition of Coherent
On January 19, 2021, Lumentum Holdings Inc., a designer and manufacturer of innovative optical and photonic products, and Coherent, Inc., a global supplier of industrial and fiber laser solutions, announced a definitive agreement under which Lumentum will acquire Coherent in a cash and stock transaction valued at $5.7 billion. Wilson Sonsini Goodrich & Rosati is advising Lumentum on the transaction.
Client Highlights
11.27.17
Barracuda Networks to Be Acquired by Thoma Bravo for $1.6 Billion
On November 27, 2017, Barracuda Networks, a leading provider of cloud-enabled security and data protection solutions, announced that it has entered into an agreement to be acquired by leading private equity investment firm Thoma Bravo in an all-cash transaction valued at approximately $1.6 billion. Wilson Sonsini is representing Barracuda Networks in the transaction.